Tafluprost 0.0015%

DRUG2 trials

Sponsors

Santen Oy, FinnMedi Oy

Conditions

Ocular HypertensionOpen-Angle Glaucoma

Phase 3

Pharmacodynamics of Tafluprost 0.0015% Eye Drops: a Comparison Between the Preserved and Unpreserved Formulation

CompletedNCT00918346

Santen OyOcular Hypertension, Open-Angle Glaucoma

Start: 2005-09-30End: 2006-04-30Updated: 2010-12-28

Phase 4

The Effects of Preservative-free Prostaglandin Eye Drops in Sign and Symptoms on the Eyes of Patients With Glaucoma

CompletedNCT01369771

FinnMedi OyOcular Hypertension, Open-Angle Glaucoma

Start: 2010-08-31End: 2012-06-30Updated: 2014-10-28